Cite

HARVARD Citation

    Codarri Deak, L. et al. (2023). Beyond checkpoint inhibition: PD-1 cis-targeting of an IL-2Rβγ-biased interleukin-2 variant as a novel approach to build on checkpoint inhibition. Oncoimmunology. p. . [Online]. 
  
Back to record